Suchbegriffe: MONOCROTALINE - TOXICITY , . Treffer: 3
Alaa, M; Abdellatif, M; Tavares-Silva, M; Oliveira-Pinto, J; Lopes, L; Leite, S; Leite-Moreira, AF; Lourenço, AP
Right ventricular end-diastolic stiffness heralds right ventricular failure in monocrotaline-induced pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2016; 311(4):H1004-H1013
Doi: 10.1152/ajpheart.00202.2016
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Morty, RE; Nejman, B; Kwapiszewska, G; Hecker, M; Zakrzewicz, A; Kouri, FM; Peters, DM; Dumitrascu, R; Seeger, W; Knaus, P; Schermuly, RT; Eickelberg, O
Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.
Arterioscler Thromb Vasc Biol. 2007; 27(5): 1072-1078.
Doi: 10.1161/ATVBAHA.107.141200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hanumegowda, UM; Copple, BL; Shibuya, M; Malle, E; Ganey, PE; Roth, RA
Basement membrane and matrix metalloproteinases in monocrotaline-induced liver injury.
Toxicol Sci. 2003; 76(1):237-246
Doi: 10.1093/toxsci/kfg222
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar